Time to death, airway wall inflammation and remodelling in fatal asthma

被引:49
作者
James, AL [1 ]
Elliot, JG
Abramson, MJ
Walters, EH
机构
[1] Sir Charles Gairdner Hosp, W Australian Sleep Disorders Res Inst, Nedlands, WA 6009, Australia
[2] Univ W Australia, Sch Med & Pharmacol, Perth, WA, Australia
[3] Monash Univ, Cent & Eastern Clin Sch, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[4] Univ Tasmania, Cardioresp Res Grp, Hobart, Tas, Australia
关键词
airway inflammation; fatal asthma; remodelling; salbutamol;
D O I
10.1183/09031936.05.00146404
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Fatal asthma is characterised pathologically by airway wall remodelling, eosinophil and neutrophil infiltration, accumulation of mucus in the airway lumen and smooth muscle shortening. The durations of fatal attacks of asthma show a clear bimodal distribution. Airway smooth muscle contraction and the accumulation of luminal mucus may contribute to death from asthma and relate to time to death. The current authors have examined these two components in uninflated lung tissue in cases of fatal asthma from the second Victorian asthma mortality study. Based on time from onset of symptoms to death, cases fell into two distinct groups: short course <3 (1.5 +/- 0.6 mean +/- SD) h; and long course >8 (12.3 +/- 5.9) h. Short course cases had more muscle shortening, higher levels of salbutamol and higher ratios of neutrophils to eosinophils than long course cases, who tended to have more mucus in the lumen. In conclusion, this study confirms the dichotomy of both time to death and the eosinophil/ neutrophil ratio in cases of fatal asthma. It suggests that in short course cases acute airway narrowing is due, predominantly, to bronchoconstriction despite higher blood levels of salbutamol. Mucus accumulation may be more important in long course cases.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 32 条
[12]   Gas chromatographic mass spectrometric determination of beta(2)-agonists in postmortem blood: Application in forensic medicine [J].
Couper, FJ ;
Drummer, OH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 685 (02) :265-272
[13]  
Couper FJ, 1999, J FORENSIC SCI, V44, P523
[14]  
CRANE J, 1989, LANCET, V1, P917
[16]   Risk of severe life threatening asthma and beta agonist type: An example of confounding by severity [J].
Garrett, JE ;
Lanes, SF ;
Kolbe, J ;
Rea, HH .
THORAX, 1996, 51 (11) :1093-1099
[17]   The pathology of bronchial asthma [J].
Huber, HL ;
Koessler, KK .
ARCHIVES OF INTERNAL MEDICINE, 1922, 30 (06) :689-760
[18]   Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial [J].
Israel, E ;
Chinchilli, VM ;
Ford, JG ;
Boushey, HA ;
Cherniack, R ;
Craig, TJ ;
Deykin, A ;
Fagan, JK ;
Fahy, JV ;
Fish, J ;
Kraft, M ;
Kunselman, SJ ;
Lazarus, SC ;
Lemanske, RF ;
Liggett, SB ;
Martin, RJ ;
Mitra, N ;
Peters, SP ;
Silverman, E ;
Sorkness, C ;
Szefler, SJ ;
Wechsler, ME ;
Weiss, ST ;
Drazen, JM .
LANCET, 2004, 364 (9444) :1505-1512
[19]   THE MECHANICS OF AIRWAY NARROWING IN ASTHMA [J].
JAMES, AL ;
PARE, PD ;
HOGG, JC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (01) :242-246
[20]   THE USE OF THE INTERNAL PERIMETER TO COMPARE AIRWAY SIZE AND TO CALCULATE SMOOTH-MUSCLE SHORTENING [J].
JAMES, AL ;
HOGG, JC ;
DUNN, LA ;
PARE, PD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (01) :136-139